(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.41%) $924.25
(0.32%) $0.935
(0.80%) $11.04
(0.18%) $0.801
(-0.32%) $91.87
Live Chart Being Loaded With Signals
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, imports, and distributes various pharmaceutical products. The company operates through two segments, Sagent Group and Nichi-Iko Group...
Stats | |
---|---|
Today's Volume | 5.21M |
Average Volume | 4.06M |
Market Cap | 2.47B |
EPS | ¥0 ( 2023-05-11 ) |
Last Dividend | ¥10.00 ( 2022-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 0.0000000 |
ATR14 | ¥4.97 (0.00%) |
Volume Correlation
Nichi-Iko Pharmaceutical Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nichi-Iko Pharmaceutical Correlation - Currency/Commodity
Nichi-Iko Pharmaceutical Financials
Annual | 2022 |
Revenue: | ¥16 907.73B |
Gross Profit: | ¥3 331.59B (19.70 %) |
EPS: | ¥128.01 |
FY | 2022 |
Revenue: | ¥16 907.73B |
Gross Profit: | ¥3 331.59B (19.70 %) |
EPS: | ¥128.01 |
FY | 2022 |
Revenue: | ¥179.06B |
Gross Profit: | ¥3.97B (2.21 %) |
EPS: | ¥-1 500.00 |
FY | 2021 |
Revenue: | ¥188.22B |
Gross Profit: | ¥21.25B (11.29 %) |
EPS: | ¥-65.28 |
Financial Reports:
No articles found.
Nichi-Iko Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
First Dividend | ¥12.00 | 2008-05-27 |
Last Dividend | ¥10.00 | 2022-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 29 | -- |
Total Paid Out | ¥380.90 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.01 | -- |
Div. Sustainability Score | 9.48 | |
Div.Growth Potential Score | 2.02 | |
Div. Directional Score | 5.75 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8135.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7482.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6706.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
6055.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
4732.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3978.T | Ex Dividend Knight | 2023-12-28 | Annually | 0 | 0.00% | |
3186.T | Ex Dividend Junior | 2023-11-29 | Annually | 0 | 0.00% | |
2180.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
9048.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7940.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0400 | 1.500 | 9.20 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0137 | 1.200 | 9.54 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0717 | 1.500 | -0.315 | -0.472 | [0.1 - 1] |
payoutRatioTTM | 0.555 | -1.000 | 4.45 | -4.45 | [0 - 1] |
currentRatioTTM | 1.440 | 0.800 | 7.80 | 6.24 | [1 - 3] |
quickRatioTTM | 0.617 | 0.800 | -1.074 | -0.859 | [0.8 - 2.5] |
cashRatioTTM | 0.584 | 1.500 | 7.86 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.185 | -1.500 | 6.92 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 92.82 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 119.18 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 86.82 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.474 | -1.500 | 8.11 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.202 | 1.000 | 9.97 | 9.97 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0414 | 1.000 | -1.172 | -1.172 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.121 | 1.000 | -0.438 | -0.438 | [0.2 - 2] |
assetTurnoverTTM | 0.344 | 0.800 | -1.042 | -0.833 | [0.5 - 2] |
Total Score | 9.48 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 0.478 | 1.000 | -0.0527 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0717 | 2.50 | -0.202 | -0.472 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 86.82 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 119.18 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.555 | 1.500 | 4.45 | -4.45 | [0 - 1] |
pegRatioTTM | -0.000222 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0651 | 1.000 | -0.872 | 0 | [0.1 - 0.5] |
Total Score | 2.02 |
Nichi-Iko Pharmaceutical
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, imports, and distributes various pharmaceutical products. The company operates through two segments, Sagent Group and Nichi-Iko Group. It primarily focuses on the production of generic drugs. The company offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products. It also provides treatments for circulatory, digestive, respiratory, central and peripheral nervous systems, and others. In addition, the company engages in the packaging design business. Further, it exports its products. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators